Maki Miyamoto

1.7k citations
59 papers · 1.2k indexed · h-index 19
Topics
Receptor Mechanisms and Signaling (8 papers)Cholesterol and Lipid Metabolism (7 papers)Hormonal Regulation and Hypertension (7 papers)
Partner nations
JapanUnited StatesChina

In The Last Decade

Maki Miyamoto

54 papers receiving 1.2k citations

Peers

Maki Miyamoto
Comparison fields: 5 of 117
  • Molecular Biology 518
  • Oncology 203
  • Organic Chemistry 173
  • Cellular and Molecular Neuroscience 139
  • Cell Biology 117
Replace Aijun Hao with:
Aijun Hao China
Vincenzo Giuseppe Nicoletti Italy
Hejiang Zhou China
Zhuang Miao China
Zhiyong He China
Tianya Liu China
Yasuhiro Kita Japan
Enxiang Tao China
Jinpyo Hong South Korea
May Khanna United States
Maki Miyamoto relative to Aijun Hao China Aijun Hao's profile →
Citations per field
00.5×4.9×
Aijun Hao · 1×
Citations per year

Countries citing papers authored by Maki Miyamoto

Since Specialization
Citations

This map shows the geographic impact of Maki Miyamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maki Miyamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maki Miyamoto more than expected).

Fields of papers citing papers by Maki Miyamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maki Miyamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maki Miyamoto. The network helps show where Maki Miyamoto may publish in the future.

Co-authorship network of co-authors of Maki Miyamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Maki Miyamoto. A scholar is included among the top collaborators of Maki Miyamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maki Miyamoto. Maki Miyamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 12
4 61
5 18
6 46
7 21
8 4
9 4
10
Radiation-induced lung injury outside the irradiated area after radiation therapy for breast cancer
1
11 15
12 0
13 55
14 9
15 19
16 2
17 9
18 8
19 24
20 1

About Maki Miyamoto

Maki Miyamoto is a scholar working on Microbiology, Oncology and Aging, having authored 59 papers that have together received 1.2k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (8 papers), Cholesterol and Lipid Metabolism (7 papers) and Hormonal Regulation and Hypertension (7 papers). The work is most often cited by research in Aging (31 citations), Biological Psychiatry (31 citations) and Microbiology (9 citations). Maki Miyamoto has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Yoshimichi Ohki, Momoko Ohori, Toshiya Nishi, Satoru Asahi, Ken‐ichi Naruo, Yasuyoshi Arikawa, Hiroyuki Kimura, Shigenori Ohkawa, Naoshi Hirai and Toshimasa Tanaka. Their work appears in journals such as Nature Communications, Gastroenterology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026